Secondary Effects of Hypochlorite Treatment on the Emerging Pollutant Candesartan: The Formation of Degradation Byproducts and Their Toxicological Profiles
- PMID: 34198752
- PMCID: PMC8200957
- DOI: 10.3390/molecules26113422
Secondary Effects of Hypochlorite Treatment on the Emerging Pollutant Candesartan: The Formation of Degradation Byproducts and Their Toxicological Profiles
Abstract
In recent years, many studies have reported the frequent detection of antihypertensive agents such as sartans (olmesartan, valsartan, irbesartan and candesartan) in the influents and effluents of wastewater treatment plants (WWTPs) and in the superficial waters of rivers and lakes in both Europe and North America. In this paper, the degradation pathway for candesartan (CAN) was investigated by simulating the chlorination process that is normally used to reduce microbial contamination in a WWTP. Twelve isolated degradation byproducts (DPs), four of which were isolated for the first time, were separated on a C-18 column by employing a gradient HPLC method, and their structures were identified by combining nuclear magnetic resonance and mass spectrometry and comparing the results with commercial standards. On the basis of these results, a mechanism of formation starting from the parent drug is proposed. The ecotoxicity of CAN and its DPs was studied by conducting a battery of ecotoxicity tests; bioassays were performed using Aliivibrio fischeri (bacterium), Daphnia magna (planktonic crustacean) and Raphidocelis subcapitata (alga). The ecotoxicity results shed new light on the increased toxicity of DPs compared with the parent compound.
Keywords: Aliivibrio fischeri; Daphnia magna; Raphidocelis subcapitata; battery toxicity test; candesartan; chlorination; degradation byproducts; hypochlorite; water treatment.
Conflict of interest statement
The authors declare no conflict of financial interests.
Figures




Similar articles
-
LC and NMR Studies for Identification and Characterization of Degradation Byproducts of Olmesartan Acid, Elucidation of Their Degradation Pathway and Ecotoxicity Assessment.Molecules. 2021 Mar 22;26(6):1769. doi: 10.3390/molecules26061769. Molecules. 2021. PMID: 33809869 Free PMC article.
-
Disinfection by-products and ecotoxic risk associated with hypochlorite treatment of irbesartan.Sci Total Environ. 2020 Apr 10;712:135625. doi: 10.1016/j.scitotenv.2019.135625. Epub 2019 Nov 20. Sci Total Environ. 2020. PMID: 32050394
-
Percarbonate mediated advanced oxidation of irbesartan: A suitable alternative to chlorination?Sci Total Environ. 2024 Oct 15;947:174730. doi: 10.1016/j.scitotenv.2024.174730. Epub 2024 Jul 16. Sci Total Environ. 2024. PMID: 39002581
-
Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment.Environ Sci Pollut Res Int. 2014 Sep;21(18):10830-9. doi: 10.1007/s11356-014-3060-z. Epub 2014 Jun 6. Environ Sci Pollut Res Int. 2014. PMID: 24898294
-
Candesartan cilexetil.Profiles Drug Subst Excip Relat Methodol. 2012;37:79-112. doi: 10.1016/B978-0-12-397220-0.00003-9. Epub 2012 Mar 19. Profiles Drug Subst Excip Relat Methodol. 2012. PMID: 22469317 Review. No abstract available.
References
-
- Vieira W.T., de Farias M.B., Spaolonzi M.P., da Silva M.G.C., Vieira M.G.A. Endocrine-disrupting compounds: Occurrence, detection methods, effects and promising treatment pathways–a critical review. J. Environ. Chem. Eng. 2020:104558. doi: 10.1016/j.jece.2020.104558. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources